¤A«¬¥æ·P¯«¸g§@¥Î¾¯¤Î®ð³Ý¥ÎÃħl¤J¾¯

£]-Agonists AndInhalant for Asthma

¥Ö½èÃþ©T¾J§l¤J¾¯³q½×

¡@

£]-¥æ·P¯«¸g§@¥Î¾¯³q½×

¡@


DL-Methylephedrine HCl  Tablet 25mg Tablet

Adrenalin inj. (Epinephrine 1ml/ml/amp.)

Lungtec Tab. (Bambuterol Hydrochloride 10mg/Tab.)

Buventol Easyhaler 200 micrograms/Dose (Salbutamol 200mcg/dose)

Ventolin Inhaler 100 micrograms (Salbutamol 100mcg/dose)

Seretide Evohaler  250mcg (250mcg fluticasone, 25mcg Salmeterol / dose)

Seretide Accuhaler 250mcg (250mcg fluticasone, 50mcg Salmeterol / dose)

Symbicort 120 doses (160mcg budesonide, 4.5mcg formoterol / dose)

Ipratran Inhalation Solution ( Ipratropium 0.25mg/ml  2ml/amp.)

Saldolin Inhalation Solution (Salbutamol 2mg/ml  2.5ml/amp.)

Butanyl Inhalation Solution  (Terbutaline Sulfate 2.5mg/ml  2ml/amp.)


¡m¥Ö½èÃþ©T¾J§l¤J¾¯³q½×¡n

¡iÃIJz§@¥Î¡j

¦¹Ãþ»s¾¯ÄÝ©ó¦X¦¨ªºµÇ¤W¸¢¥Ö½èÃþ©T¾J¡A¨ã¦³¿}½èÃþ©T¾J (glucocorticoid) ªº§@ ¥Î¤ÎÃĮġC¥¦­Ìªº§Üµoª¢§@¥Î¤Î¼QÃú¾¯«¬ÃÄ«~¦bªÍ¤¤ªº½T¹ê§@¥Î¾÷Âà©|¤£²M·¡¡A¿} ½èÃþ©T¾J¥i¯à·|­°§Cµoª¢²Ó­Mªº¼Æ¥Ø¤Î¬¡©Ê¡A¨ó§U b-¥æ·P¯«¸g§@¥Î¾¯«P¶i cyclic AMP ªº²£¥Í¡A§í¨î¤ä®ðºÞ¦¬ÁY©Îª½±µ²£¥Í¦Ù¦×©ñÃP§@¥Î¡C¨Ï¥Î¼QÃú¾¯¥i¥H±o¨ì¨¬°÷ ªº§½³¡®ÄªG¨Ã¥B´î¤Ö¥þ¨­©Êªº§@¥Î¡C

ÃİʾÇ

¡EBeclomethasone dipropionate¡G¥H¥ô¦ó³~®|µ¹ÃÄ¡A§l¦¬¬Ò«Ü¨³³t¡C©|µL¸ê®ÆÅã¥Ü be- clomethasone ©Î¨ä¥NÁª«·|»W¿n¦bÅ餺¡CªÍ³¡¬°­«­n¥NÁ¾¹©x¡C¥D­n¥ÑÁT«K±Æ ¥X¡A¤Ö©ó 10% ªºÃÄ«~¥Ñ§¿¤¤±Æ¥X¡C ¡EDexamethasone sodium phosphate¡G¨ã°ª¤ô·»©Ê¡A¨ä¼QÃú·L²É¯à¨³³t©ó¤ä®ðºÞ¤Î¨ä¤À ªcª«¤¤·»¸Ñ¡C¨C¤Ñ¼Q 12 ¤U®É¡A¬ù¦³40-60% ÃÄ«~·|³Q§l¦¬ (§Y 0.4-0.6mg dexamethasone)¡C ¡ETriamcinolone acetonide¡G«Ü§Ö¥ÑªÍ³¡²M°£¡A¬ù©ó 1-2 ¤p®É¥i¹F³Ì°ª¦å¤¤¿@«×¡A¥D­n ¥ÑÁT«K±Æ¥X¡C ¡EFlunisolide¡G§l¤J 1mg flunisolide¡A¨ä¥þ¨­§l¦¬¶q¬ù¬° 40%¡A§l¦¬ªºÃÄ«~«Ü§Ö¸g¥Ñ¨x Ŧ¥NÁ¡A¦å¤¤¥b°I´Á¬ù¬° 1.8 ¤p®É¡C ¡EBudesonide¡G§l¤J«á¡A¬ù©ó 15-45 ¤ÀÄÁ«á¥i¹F³Ì°ª¦å¤¤¿@«×¡A¥ÍÅé¥i¥Î²v¬ù¬° 73%¡CBudesonide ·|¥NÁ¦¨¤£¨ã¬¡©Ê¥NÁª«¡A«Ü§Ö¥ÑÅ餺±Æ¥X¡A¥b°I´Á¬ù 2 ¤p ®É¡C

¡i¾AÀ³¯g¡j

¡E¤ä®ðºÞ®ð³Ýªº±±¨î¡G»P¨ä¥LÃÄ«~¨Ö¥Î¡A¦p xanthines ©Î¥æ·P¯«¸g§@¥Î¾¯¡AªvÀøºC©Ê¯f ±w¡A¥]¬A±µ¨ü¥þ¨­©ÊÃþ©T¾JªvÀøªÌ¡A©Î¥H«D©T¾JÃþÃÄ«~µLªk±±¨î¯gª¬¡A¦ý¤S¤£ ©y¨Ï¥Î¥þ¨­©ÊÃþ©T¾JªvÀøªÌ¡C ¡E¥i¥H¥Î¤ä®ðºÞÂX±i¾¯©Î«D©T¾JÃþÃÄ«~±±¨îªº¯f¤H¤£©y¨Ï¥Î¦¹ÃþÃÄ«~¡A¥ç¤£©y¥Î©ó°¸ ¦Ó»Ý­n¥þ¨­©Ê¥Ö½èÃþ©T¾JªvÀøªº¯f¤H¡A©Î«D®ð³Ý©Ê¤ä®ðºÞª¢±wªÌ¡C

¡i¸T§Ò¡j

¡E»Ý­n¿n·¥ªvÀøªº®ðºÞµjÅ˱wªÌ¡A¤£¥i¥H¦¹ÃþÃÄ«~§@¬°²Ä¤@½uªvÀø¡C ¡E¹ï»s¾¯¤¤¦¨¥÷¹L±Ó¡C ¡E¥þ¨­©ÊÅðµß·P¬V¡C

¡iª`·N¨Æ¶µ¡j

¡EµÇ¤W¸¢¥Ö½è¥\¯à¤£¥þ¡G¥Ñ¥þ¨­©Ê¥Ö½èÃþ©T¾J§ï¥Î¼QÃú©Î§l¤J¾¯ªvÀøªº®ð³Ý¯f¤H¡A´¿ ¦³¦]µÇ¤W¸¢¥Ö½è¥\¯à¤£¨¬¦Ó­P¦ºªº¯f¨Ò¡C¨Ï¥Î¥þ¨­©Ê¥Ö½èÃþ©T¾J«á¡A¤Uµø¥C¡Ð ¸£¤U¸¢¡ÐµÇ¤W¸¢¥Ö½è¶b (HPA) ¥\¯à¥i¯à»Ý­n¼Æ­Ó¤ë¤~·|«ì´_¡A¦b¦¹¬q®É¶¡¤¤¡A ­Y¯f¤H­±Á{¤â³N¡B¥~¶Ë¡B·P¬V©Î¸z­Gª¢¡A¥i¯à¥X²{µÇ¤W¸¢¥Ö½è¥\¯à¤£¥þ¯gª¬¡C ¦¹®É¡AÀ³¥ß§Yµ¹¤©°ª¾¯¶q¥þ¨­©Êªº¥Ö½èÃþ©T¾J¡C ¡E·P¬V¡G°¸¦Ó¥i¯àµo¥Í¤f¡B«|¡B³ï³¡ªºÅðµß·P¬V (Candida albicans ©Î Aspergillus niger)¡AÁöµMµo¥Í²v¤£°ª¡A¦ý¥²¶·µ¹¤©§ÜÅðµß¾¯©Î°±¤î¼QÃú¾¯ªºªvÀø¡C ¡E«æ©Ê®ð³Ý¡G¦¹Ãþ»s¾¯¬Ò«D¤ä®ðºÞÂX±i¾¯¡A¤£¾A¥Î©ó§Ö³t¸Ñ°£¤ä®ðºÞµjÅ˯gª¬¡C­Y¥H ¤ä®ðºÞÂX±i¾¯ªvÀøµLªk§ïµ½®É¡A¯f¤HÀ³¥ß§Y§iª¾Âå®v¡A¦¹®É¥i¯à»Ý­n¨Ï¥Î¥þ¨­ ©Ê¥Ö½èÃþ©T¾JªvÀø¡C ¡E¥Ñ¥þ¨­©Ê¥Ö½èÃþ©T¾J§ï¥Î¼QÃú©Î§l¤J¾¯¡A­ì¨Ó³QÀ£§íªº¹L±Ó¯gª¬¥i¯à·|¥X²{ (¦p»ó ª¢¡Bµ²½¤ª¢©ÎÀã¯l)¡C¦b°±ÃĹLµ{¤¤¡AÁöµM©I§l¥\¯àºû«ù¨}¦n¬Æ©Î§ïµ½¡A¬Y¨Ç¯f ¤H¤´¥i¯à·|¥X²{§ÙÂ_¯gª¬¡A¦pÃö¸`¦Ù¦×µh¡B¯h¾Î¤Î¼~Æ{µ¥¡C ¡EÃh¥¥¥ÎÃįżơGTriamcinolone D ¯Å¡AFlunisolide C ¯Å¡C¿}½èÃþ©T¾J¹ïø¥¾¦Ãþ°Êª«¨ã ¦³­P·î©Ê¡A¦ý©|µL¹ïÃh¥¥°ü¤k¤§¬ã¨s¡CÃh¥¥´Á¨Ï¥Î¦¹ÃþÃÄ«~ªº°ü¤k©Ò¥ÍªºÀ¦¨à À³ª`·N¬O§_¦³µÇ¤W¸¢¥Ö½è¥\¯à¤£¥þªº¯gª¬¡C ¡E±Â¨Å´Á¡G¥þ¨­©Ê¿}½èÃþ©T¾J¥i¤Àªc¦Ü¨Å¥Ä¤¤¡A§l¤J©Êªº¥Ö½èÃþ©T¾J©|¤£²M·¡¬O§_·| ¶i¤J¨Å¥Ä¤¤¡AÀ³«Øij°±¤î±Â¨Å©Î°±ÃÄ¡C ¡EªA¥Î beclomethasone ¤Î flunisolide ·|¦³¶Ý¥ì¬õ©ÊªÍ³¡®û¼í (pulmonary infiltrates with eosinophilia) ªº²{¶H¡A¥i¯à¥ÑÃÄ«~¥»¨­©Î½á§Î¾¯¤Þ°_¡C

¡i°Æ§@¥Î¡j

¡E§½³¡¡G³ïÄV¦³¨ë¿E·P¡BÁn­µ¼R°×¡B¤f°®¤Î«y¹Â¡C¥X²{¤f¡B«|¡B³ï³¡ªºÅðµß·P¬V®É¡A °±¤î¥Ö½èÃþ©T¾J¨Ãµ¹¤©§ÜÅðµßÃÄ«~¥i¥ß§Y½w¸Ñ¯gª¬¡C ¡E¥þ¨­©Ê¡GHPA ¥\¯à³QÀ£§í¡C¦¨¤H³sÄò 1 ­Ó¤ë¨C¤é¨Ï¥Î beclomethasone 1600mg ´¿¦³ HPA ¥\¯à³QÀ£§íªº³ø§i¡C¥Ñ¥þ¨­©Ê¥Ö½èÃþ©T¾JªvÀø§ï¥Î¼QÃú¾¯ªvÀøªº®ð³Ý¯f ¤H¡A´¿¦³¦]µÇ¤W¸¢¥Ö½è¥\¯à¤£¨¬¦Ó­P¦ºªº¯f¨Ò¡C°Ñ¾\¡iª`·N¨Æ¶µ¡j¡C¨Ï¥Î beclo-methasone ´¿¦³¤ä®ðºÞµjÅˤΥX¯lªº³ø§i¡C ¡E¿}½èÃþ©T¾Jªº¥þ¨­©Ê§@¥Î¡A°Ñ¾\²Ä 267 ­¶¡C

¡i¯f±w±Ð¨|¸ê°T¡j

¡E¿í·Ó»¡©ú®Ñ¨Ï¥Î¤èªkªAÃÄ¡C ¡E¦¹ÃþÃÄ«~¥Î³~¬°¹w¨¾©Ê¡A¤£©yªvÀø«æ©Ê®ð³Ýµo§@¡A¥­±`À³¿í·Ó«ü¥Ü¨Ï¥Î¡C ¡E¨C¦¸¾¯¶q»Ý§l¤J 2 ¤U¥H¤W®É¡A¨C¤U¤§¶¡À³¶¡¹j 1 ¤ÀÄÁ¡C ¡E¦P®É¨Ï¥Î§l¤J©Ê¤ä®ðºÞÂX±i¾¯®É (¦p isoproterenol, metaproterenol, epinephrine µ¥)¡A À³¥ý¨Ï¥Î¤ä®ðºÞÂX±i¾¯¡A¼Æ¤ÀÄÁ«á¦A¥Î¥Ö½èÃþ©T¾J¼QÃú¾¯¡A¤~¯àÀ°§UÃþ©T¾J¼Q Ãú·L²É¶i¤J¤ä®ðºÞ¤¤¡C ¡E¨Ï¥Î«á¥i¥H²M¤ô©Îº¤¤f¤ôº¤¤f¡A¥H´î¤Ö¤f°®¤ÎÁn­µ¼R°×ªº°Æ§@¥Î¡C ¡E­Y¦³³ïÄVµh©Î¤fµÄ¯kµhªº¯gª¬µo¥Í¡AÀ³¥ß§Y§iª¾Âå®v¡C

¡i¥Îªk¡j

¡E¨Ö¥Î¥þ¨­©ÊÃþ©T¾J¡G¥Ñ¥þ¨­©ÊÃþ©T¾J§ï¥Î¼Qª«©Î§l¤J¾¯®É¡AHPA ¥\¯à¥i¯à»Ý­n¹F 12 ­Ó¤ë¤~¯à«ì´_¡C¨Ï¥Î¤§«e¡AÀ³¥ý±±¨î®ð³Ý¯gª¬¡C³Ìªì 1 ¬P´Á¡A¥i¥H¦P®É¨Ï¥Î§l ¤J¾¯¤Îºû«ù¾¯¶qªº¥þ¨­©ÊÃþ©T¾J¡A¥H«á¬ù¨C 1-2 ¬P´Á¡A®Ú¾Ú¯f¤H¤ÏÀ³¡A­°§C¥þ ¨­©ÊÃþ©T¾Jªº¾¯¶q¡C ¡E¦b³vº¥°±ÃĮɡA¬Y¨Ç¯f¤H¥i¯à·|¦³Ãþ©T¾Jªº§ÙÂ_¯gª¬¥X²{¡AÀ³Ä~Äò¨Ï¥Î§l¤J¾¯¡A¦ý ¥²¶·±K¤ÁÆ[¹î¯f¤H¡C­Y¥X²{µÇ¤W¸¢¥Ö½è¥\¯à¤£¥þ¯gª¬¡AÀ³¼È®É©Êªºµ¹¤©¤@°ª¾¯ ¶q¥þ¨­©ÊÃþ©T¾J¡A¨Ã±N´î¶qªº³t«×­°§C¡C­Y­±Á{ÄY­«¥~¶Ë©ÎÀ£¤O®É¡AÀ³¸É¥R¥þ ¨­©ÊªºÃþ©T¾J¡C°Ñ¾\¡iª`·N¨Æ¶µ¡j¡C

¡@

¡m£]-¥æ·P¯«¸g§@¥Î¾¯³q½×¡n

¡iÃIJz§@¥Î¡j

³o¨ÇÃĪ«¯à¨ë¿E¥æ·P¯«¸g a ¨ü¾¹ (´C¤¶¦åºÞ¦¬ÁY¡B®ø°£»ó¥R¦å»P¤ÉÀ£§@¥Îµ¥)¡B b1 ¨ü¾¹ (´C¤¶¤ßŦ¦¬ÁY¤Î¶Ç¾É¼W±jµ¥)»P b2 ¨ü¾¹ (´C¤¶¤ä®ðºÞÂX±i»P¦åºÞÂX±iµ¥)¡C °£¤F¤ßŦ¦åºÞ»P©I§l§@¥Î¥~¡A¨ä¥L¥æ·P¯«¸g§@¥Î¥]¬A¸z­G¹D¤Î§¿¹D¬A¬ù¦Ù¦¬ÁY (a- ¨ü¾¹)¡A¯×ªÕ¤À¸Ñ (b1-¨ü¾¹)¡A¸z­G±i¤O­°§C¡BµÇ¯À (renin) ¤Àªc¼W¥[¡B¤l®cÃP¦¢¡B«P ¶i¨xÁÞ¤À¸Ñ©M¿}·s¥Í§@¥Î (gluconeogenesis) ¤Î¯ØŦ b ²Ó­M¤Àªc (b2 ¨ü¾¹)¼W¥[¡C ¥æ·P¯«¸g§@¥Î¾¯ªº¬Û¹ï¿ï¾Ü©Ê¬OÁ{§É¤W¥ÎÃÄ¿ï¾Üªº¨M©w¦]¯À¡A¤]¯à¹w´ú¥i¯àµo ¥Íªº°Æ§@¥Î¡C¨ã b2 ¿ï¾Ü©ÊªºÃĪ«°Æ§@¥Î³Ì¤Ö¡C¸g¥Ñ§l¤J¤è¦¡§ëÃÄ¡AÃĮĥi¥H«Ü§Ö²£ ¥Í¥B¥þ¨­©Ê°Æ§@¥Î¤Ö¡C¦¹¥~¡A³o¨ÇÃĪ«¯à§í¨îªÎ¤j²Ó­M (mast cells) ÄÀ©ñ²Õ´Ói¡BÃP ¦¢¦åºÞ¨Ã«P¶iÅÖ¤ò¹B°Ê¡C

¡i¾AÀ³¯g¡j

½w¸Ñ¥i°f©Ê¤ä®ðºÞµjÅ˯gª¬¡C°Ñ¾\ÃÄ«~­Ó½×¡i¾AÀ³¯g¡j¡C

¡i¸T§Ò¡j

¹ï»s¾¯¦¨¥÷±Ó·P¡B¦ñ¦³¤ß·i¹L³tªº¤ß«ß¤£¾ã»P¤ò¦a¶À¤¤¬r¤Þ°_ªº¤ß·i¹L³t¡C

¡iª`·N¨Æ¶µ¡j

¡E¯S®í¦MÀI¸s¡G¦åºÞµÎÁY¤£Ã­©w (vasomotor unstable)¡B¿}§¿¯f¡B¥Òª¬¸¢¥\¯à¤®¶i¡B«e ¦C¸¢ªÎ¤j¡B¦³µjÅ˯f¥v¡B¦Ñ¦~¤H¡Bºë¯«¯«¸g©x¯à¯f¯g (psychoneurosis) ¤Î¦³°h¤Æ ©Ê¤ßŦ¯fªºªø´Á¤ä®ðºÞ®ð³Ý©ÎªÍ®ð¸~ªº¯f¤H­nÂÔ·V¨Ï¥Î¡C ¡E§½³¡¨ë¿E¡G¯»ª¬»s¾¯¥i¯à·|¨ë¿E¤f«|©M¤ä®ðºÞÂO¡AÀ³©ó¤£¾A¥Î·»²G©ÎÄa¯B¾¯ªº±¡ªp ¤U¤~¿ï¾Ü¨Ï¥Î¡C ¡E¦p¦³¤ä®ðºÞ¿³¾Ä¡Bºò±i¡BµJ¼{©Î¥¢¯vµ¥¯gª¬¡AÀ³­°§C¾¯¶q¡C ¡E®ð³Ý¦M¶H (status asthmaticus) ©M¦å¤º®ðÅé (blood gas) ²§±`¡G¤ä®ðºÞµjÅ˲{¶H½w¸Ñ «á¡AªÍ¬¡¶q©M¦å¤º®ðÅé¥i¯à©|¥¼§ïµ½¡A¦¹®É»Ýµ¹¤©®ñ®ð»P©I§l»²§U¡C ¡E¤ßŦ¦åºÞ§@¥Î¡G¤ßŦ¯e¯f (¥]¬A«aª¬°Ê¯ß´`Àô¤£¨¬¡B¤¤­·¯f¥v¡B«aª¬°Ê¯ß¯e¯f¡B¤ß«ß ¤£¾ã©M°ª¦åÀ£)±wªÌ­nÂÔ·V¨Ï¥Î¡C³o¨ÇÃÄ«~¥i¯à¦]¯S²§Åé½è¤ÏÀ³©Î¨Ï¥Î¹L¶q¦Ó¤Þ °_¤ßŦ¬r©Ê¡C¤ß©ÐÅÖºûŸ°Ê±wªÌªº¤ß·i³t«×·|¤j´T¼W§Ö¦Ó¾É­P¤ßµ±µhµo§@¡C¨Ï ¥Î epinephrine ®É­nÄY±KºÊ´ú¡A¦]¬°°Ê¯ßÀ£¤É°ª¥i¯à·|¤Þµo¤ßµ±µh¡B¥D°Ê¯ß¯}µõ ©Î¸£¥X¦å¡C¦³¨Ç¯f¤H¨Ï¥Î¼QÃú¾¯«á¡A¦¬ÁYÀ£»PµÎ±iÀ£¦³©úÅ㪺ÅܤơC ¡E¹L«×¨Ï¥Î§l¤J¾¯¡G­«½Æ¦a¹L«×¨Ï¥Î§l¤J¾¯«á¡A°¸¦Ó·|¨Ï©I§l¹Dªºªý¤O¼W¥[¡AÀ³¥ß§Y °±ÃĨõ¹¤©¨ä¥LªvÀø¡C´¿¦³­P¦º³ø§i¡CÀ³«ü¥Ü¨Ï¥Î¼QÃú¾¯±wªÌ¡A­Yı±oÃÄ«~µL ®Ä®ÉÀ³§iª¾Âå®v¡C ¡Eªø´Á¨Ï¥Î¡Gªø´Á¨Ï¥Î ephedrine ¥i¯à²£¥ÍÃþ¦üµJ¼{ªº¯gª¬»Pºë¯«ºò±i¡A¥iµ¹¤©ÂíÀR ¾¯¡Cªø´Á©Î¹L¶q¨Ï¥Î epinephrine¡A¦å¤¤¨Å»Ä­È¤É°ª¥B¦³ÄY­«ªº¥NÁ©ʻĦå¯g¤Î µu¼Èªº¦å¿}¤É°ª¡C ¡E¿}§¿¯f¡GÀR¯ßª`®g°ª¾¯¶q salbutamol¡A·|´c¤Æ¿}§¿¯f¤Î଻Ħå¯g¡A¥i¯à»Ý¼W¥[¯Ø®q¯À ©Î¤fªA­°¦å¿}¾¯ªº¾¯¶q¡C ¡EEpinephrine ¹L¶q¨Ï¥Î©Î¦]ª`®g¥¢»~¦Ó¥´¤JÀR¯ß¡A¥i¯à·|¤Þ°_ÄY­«©Î­P©Rªº°ª¦åÀ£¤Î ¸£¦åºÞ¥X¦å¡A¤]¥i¯à¦]©PÃä¦åºÞ¦¬ÁY©M¤ßŦ¨ë¿E¦Ó¤Þ°_ªÍ¤ô¸~¡A¾É­P¦º¤`¡C¥i ¨Ï¥Î§@¥Î§Ö³tªº¦åºÞÂX±i¾¯¡A¦pµv»ÄÆQÃþ©M a-¥æ·P¯«¸gªýÂ_¾¯§@¬°«ú§Ü¾¯¡C ¡E­PÀù©Ê»P¬ðÅÜ©Ê¡G°Êª«¸ÕÅ礤¡Asalbutamol ¦b·¥°ª¾¯¶q¤U¦³­PÀù©Ê¡A¦ý¹ï¤HÅ骺¼vÅT ©|¥¼ÃÒ¹ê¡C ¡EÃh¥¥¥ÎÃįżơG *Terbutaline¡GB ¯Å¡C *Salbutamol, epinephrine, metaproterenol¡GC ¯Å¡C ¡E¤À®Y¡GÀR¯ßª`®g b2-¥æ·P¯«¸g§@¥Î¾¯·|§í¨î¤l®c¦¬ÁY (°Ñ¾\²Ä 329 ­¶¡Aterbutaline)¡C ¨ä¥L§@¥ÎÁÙ¥]¬A¦³¥À¿Ëµu¼È§C¹[¦å¯g¡BªÍ¤ô¸~©M§C¦å¿}¤Î·s¥Í¨à§C¦å¿}¡C¼QÃú ¾¯¸û¤£©öµo¥Í³o¨Ç¤ÏÀ³¡A¦ý¤´À³¤p¤ß¨Ï¥Î¡C ¡E±Â¨Å´Á¡GEpinephrine ·|¤Àªc©ó¨Å¥Ä¡A¨ä¥LÃÄ«~©|¥¼½T©w¡CªA¥Î salbutamol ®ÉÀ³ÁקK ±Â¨Å¡C ¡E¨àµ£¡G *§l¤J¾¯¡GMetaproterenol ©M salbutamol ¥Î©ó 12 ·³¥H¤U¨àµ£ªº¦w¥þ©Ê»P¦³®Ä©Ê©| ¥¼½T¥ß¡C *ª`®g¡GTerbutaline ª`®g¾¯¤£«Øij¥Î©ó¨àµ£¡CEpinephrine ¥Î©óÀ¦¨à©M¨àµ£®É­nÂÔ ·V¡A±w¦³®ð³Ý¨àµ£¨Ï¥Î«á¥i¯à¥X²{©ü³Ö²{¶H¡C *¤fªA¡GTerbutaline ¤£«Øij¥Î©ó 12 ·³¥H¤U¨àµ£¡CSalbutamol ¿õ¾¯¥Î©ó 12 ·³¥H¤U ¨àµ£ªº¦w¥þ©Ê»P¦³®Ä©Ê©|¥¼½T¥ß¡CSalbutamol ¿}¼ß¥Î©ó 2 ·³¥H¤U¨àµ£ªº¦w¥þ©Ê »P¦³®Ä©Ê«h©|¥¼½T¥ß¡CEphedrine ¯à¦³®ÄªºªvÀø¨àµ£®ð³Ý¡A¦ý¦³¤¤¼Ï¯«¸g¿³¾Ä§@ ¥Î¡A¦]¦¹±`»PÂíÀR¾¯¨Ö¥Î¡C ¡E­@ÃÄ©Ê¡Gªø´Á¨Ï¥Î¥i¯à·|²£¥Í­@ÃÄ©Ê¡A¼È®É°±ÃÄ¥i«ì´_¡C ¡EÃÄ«~ÀÝ¥Î/¨Ì¿à©Ê¡GÃÄ«~¤£¨ã¦¨Å}©Ê¡A¦ýªø´ÁÀݥΠephedrine ·|¾É­P¦k·Q©Êºë¯«¤Àµõ (paranoid schizophrenia) ¯gª¬¡A±wªÌ·|¥X²{¤ß·i¹L³t¡BÀç¾i¤£¨}¡Bµo¿N¡B«_§N¦½ ©MÀû¤ÕÂX¤j¡C ¡Eª`®g¡GÁקK¦]¥¢»~¦Ó¥´¤J¯«¸g©Î¦åºÞ¤º¡CEpinephrine ¤£­nª`®g©ó¦å²G¨Ñµ¹¶q¤Ö (¦p ¤â«ü¡B¸}³k¡B»ó¡B¦Õ¡B¥Í´Þ¾¹)©Î¦³©PÃä¦åºÞ¯e¯fªº°Ï°ì¡A¥H§K¦]¦åºÞ¦¬ÁY¤Þ°_ Ãa¦º¡CÀR¯ßª`®g®É salbutamol »P¨ä¥L b-¥æ·P¯«¸g§@¥Î¾¯¡A¥i¯à·|¤Þ°_µu¼Èªº¦å ¹[­°§C¡C ¡E¦X¨ÖªvÀø¡GSalbutamol ©Î terbutaline ¤fªA¿õ¾¯¤£«Øij»P¨ä¥L¥æ·P¯«¸g§@¥Î¾¯¨Ö¥Î¡A ¥HÁקK´c¤Æ¤ßŦ¦åºÞ¥\¯à¡CªA¥Î salbutamol ©Î terbutaline ¿õ¾¯ªº¯f¤H¡A¦b¥X²{ «æ©Ê®ð³Ýµo§@®É¡A¥i¨Ï¥Î¼QÃú¾¯«¬ªº¥æ·P¯«¸g¿³¾Ä¾¯¡A¦ý¤£¥iªø´Á¨Ö¥Î¡C

¡iÃÄ«~¥æ¤¬§@¥Î¡j

ÃÄ«~ §@¥Î
³æÓi®ñ¤Æ»Ã¯À§í¨î¾¯ »P¦åºÞ¦¬ÁY¾¯¨Ö¥Î®É­n¤p¤ß¡C
¤TÀô§ÜÆ{¾¯¡B¬Y¨Ç§Ü²Õ´Ói¾¯©M sodium levothyroxine ¥æ·P¯«¸g§@¥Î¼W±j¡C
­°¦åÀ£ÃÄ Guanethidine Reserpine, methyldopa ­°¦åÀ£§@¥Î´î®z¡C Ephedrine ¤ÉÀ£§@¥Î´î®z¡C
¹L¶qªº¤ò¦a¶À¡B§t¨E§Q§¿¾¯©Î¨ä¥L ·|¤Þµo¤ß«ß¤£¾ãªºÃĪ«¤£«Øij¨Ö¥Î epinephrine ©M ephedrine¡C«aª¬°Ê¯ß´`Àô¤£¨¬®É¡A¥i¯à¤Þµo¤ßµ±µh¡C
¨Ö¥Î¨âºØ¥æ·P¯«¸g§@¥Î¾¯ ¤ßŦ¨ë¿E»P¨ä¥L°Æ§@¥Î·|¬Û¥[¡A¤£«Øij¨Ö¥Î¡C
b-¥æ·P¯«¸gªýÂ_¾¯ (¦p propranolol) ¥æ·P¯«¸g¾¯ªº¤ßŦ»P¤ä®ðºÞ§@¥Î³Q«ú§Ü¡C
a-¥æ·P¯«¸gªýÂ_¾¯ (¦p prazosin) Epinephrine ©M ephedrine ªº¦åºÞ¦¬ÁY»P¤ÉÀ£§@¥Î³Q«ú§Ü¡C
³Á¨¤ ©M phenothiazines «ú§Ü epinephrine ªº¤ÉÀ£§@¥Î¡C
¯Ø®q¯À©Î¤fªA­°¦å¿}ÃÄ ¨Ö¥Î epinephrine ®É¥i¯à»Ý¼W¥[­°¦å¿}¾¯ªº¾¯¶q¡C

¡i°Æ§@¥Î¡j

¡E¤¤¼Ï¯«¸g¡GµJ¼{¤£¦w¡B®£Äß¡Bºò±i¡B¤¤¼Ï¿³¾Ä¡B¹B°Ê¥\¯à¤®¶i¡B¥¢¯v¡BŸ§Ý¡B¶Ý ºÎ¡B¼Éļ¡Bµê®z¡B¯t·w¡BÀY©ü¡BÀYµh¡B¼é¬õ¡B»a¥Õ»P¥X¦½¡C *ª`®g ephedrine¡G´¿¦³ºë¯«¯¿¶Ã¡Bĸ¦k¤Î¤Ûıªº³ø§i¡C *ª`®g epinephrine¡G¦]¦åÀ£«æ¼@¤W¤É¦Ó¤Þ°_¸£¥X¦å¡A¯S§O®e©öµo¥Í©ó¦³¸£¦åºÞ¯e ¯fªº¦Ñ¦~±wªÌ¡C¥t¥~¥i¯à¤Þµo¤U¦C¯gª¬¡Gºë¯«¹B°Ê©Ê¿E¶V (psychomotor agitation)¡B©w¦V¤O»Ùê¡B°O¾Ð¤O»Ùê¡B§ðÀ»©Ê¦æ¬°¡BÅå·W¡B¤Ûı¡B¦³¦Û±þ©Î±þ ¤H¶É¦V¡Bºë¯«¤Àµõ«¬«ä·Q²§±` (schizophrenic-type thought disorders) ©Î¦k·Q©Ê ¤Û·Q¡B¥b¨­¤£¹E©M»jµï½¤¤U¥X¦å¡C¨àµ£¥i¯à·|µo¥Í©ü³Ö¡C¤Úª÷´Ë¤ó¯g±wªÌªº»ø µw©MŸ§Ý²{¶H¥i¯à·|µu¼È´c¤Æ¡C ¡E¤ßŦ¦åºÞ¡G¤ß±ª¡B¦åÀ£ÅܤơB¤ß·i¹L³t¡B¤ß«ß¤£¾ã¡B¤ß«Ç¦­´Á¦¬ÁY (¨u¨£)¡B­P©R©Ê ¤ß«ÇÅÖºûŸ°Ê (ª`®g epinephrine)¡B¯Ý³¡¤£¾A¡B¤ßµ±µh¡B¯Ý¤f¤£¾A©M¤ßªÍ°±¤î¡C ¡EªÍ¡G©I§l§xÃø¡BªÍ¤ô¸~¡B«y¹Â»P¤ä®ðºÞµjÅË¡C ¡E¥Í´Þªc§¿¡Gª`®g epinephrine ©M ephedrine ¥i¯à¤Þ°_µÇŦ¦åºÞ¦¬ÁY¦Ó¨Ï§¿¶q´î¤Ö¡C»H ¯Ö¬A¬ù¦ÙµjÅË¥i¯à¤Þ°_±Æ§¿§xÃø¤Î¯kµh¡C«e¦C¸¢¯fÅܱwªÌ¥i¯àµo¥Í§¿º¢¯d²{ ¶H¡C ¡E¸z­G¡Gäú¤ß¡B¹Ã¦R¡B¹½­¹¡B­Gµh»P¨ýı²§±`¡C ¡E§½³¡¤ÏÀ³¡G¦P¤@³¡¦ì­«½Æª`®g¥i¯à¤Þ°_¦åºÞ¦¬ÁY¦ÓÃa¦º¡Cª`®g³¡¦ì¥i¯à¦³ëC³Â¯l¡B ­·¶ô¯l©M¥X¦å²{¶H (epinephrine)¡C ¡E¨ä¥L¡G¦Ù¦×©âÝz¡B¦Õ®Ç¸¢¸~µÈ (ªø´Á¨Ï¥Î isoproterenol)¡B¤f«|°®Àê©Î¨ë¿E¡C´¿¦³ª` ®g epinephrine ¤Þ°_¤¤¼Ïµøºô½¤°Ê¯ßªý¶ëªº³ø§i¡C

¡i¤¤¬r»P¹L¶q¡j

¡E§l¤J¾¯¡G *¯gª¬¡G°Æ§@¥Î¥[­«¡C¥i¯àµo¥Í¤ßµ±µh»P°ª¦åÀ£¡Cªì´Á¦åÀ£¥i¯àµy·L¤É°ª¡A¦ýÀH «á­°§C¨Ã¥i¯à¤Þ°_¥ð§J¡C *ªvÀø¡G¤@¯ë¤ä«ù©ÊÀøªk¡CµJ¼{¤£¦w®É¥iµ¹¤©ÂíÀR¾¯ (barbiturates)¡C¥i¨Ï¥Î¨ã¤ß Ŧ¿ï¾Ü©Êªº b-ªýÂ_¾¯ (¦p metoprolol »P atenolol)¡A¦ý¦³¤Þµo®ð³Ýµo§@ªº¦MÀI¡C ¤£©y³zªR¡C ¡E¥þ¨­§@¥Î¾¯¡G *¯gª¬¡G¤ß±ª¡B¤ß·i¹L³t¡B¤ß·i®}½w¡B´Á¥~¦¬ÁY¡B¤ßŦ¶Ç¾ÉªýÂ_¡B¯Ýµh¡B§C¦å ¹[¡B¦åÀ£¤É°ª¡Bµo¿N¡B¬È´H¡B§N¦½¡B¥Ö½§»a¥Õ¡Bäú¤ß¡B¹Ã¦R¡B´²Àû¡B¥¢¯v¡BµJ ¼{¡B¾_Ÿ¡Bĸ¦k¡BµjÅË¡Bµê²æ©M©ü°g¡C *ªvÀø¡G°±Ãĩέ°§C¾¯¶q§Y¥i±±¨î¡C¯fªpÄY­«®É¡A¥i¨Ï¥Î b-ªýÂ_¾¯ (propranolol)¡A¦ý¥i¯à¨Ï©I§l¹Dªý¶ë§ó¥[´c¤Æ¡CªvÀø¥]¬A¤@¯ë¤ä«ù©ÊÀøªk¡C

¡i¯f±w±Ð¨|¸ê°T¡j

¡E§l¤J¾¯¡G *¨Ï¥Î«e½Ð¸Ô¾\»¡©ú®Ñ¡C *¹L¶q¨Ï¥Î·|²£¥Í°Æ§@¥Î©Î³à¥¢ÃĮġC *¦b²Ä 2 ¦¸§l®ð¶i¦æ¤@¥b®É¼Q¤JÃľ¯¡A¦¹®É©I§l¹DºZ¶}¡AÃúª¬²G¤À§G³Ì¼s¡C *¨C¦¸©Ò»Ý¾¯¶q¶W¹L 1 ¤U®É¡A¨â¦¸§l¤J¶¡À³¦Ü¤Ö¶¡¹j¤@¬q®É¶¡¡A¥H¨ú±o³Ì¨ÎÃÄ ®Ä¡CIsoproterenol ©M epinephrine ¬° 3-5 ¤ÀÄÁ¡Ametaproterenol ¬° 10 ¤ÀÄÁ¡C *¨Ï¥Î«á¤´µLªk±±¨î¯gª¬©Î¥X²{¯Ýµh©Î·w¯t®É¡A­n§iª¾Âå®v¡C ¡E¥þ¨­§@¥Î¾¯¡G *¤£­n¾Õ¦Û¼W¥[¾¯¶q¡C­Y¦³¸z­G¤£¾A¡A¥iÀHÀ\ªA¥Î¡C *¦Þ¤U§t¿õ (isoproterenol)¡G¸m©ó¦Þ¤U·»¸Ñ¡A¤£¥i§]ªA¡C *¥i¯à¤Þ°_ºò±i¡BµJ¼{¤£¦w¡B¥¢¯v (¤×¨ä¬O ephedrine)¡A­Y´î¶q¤´µLªk§ïµ½®É¡A´N ­n§iª¾Âå®v¡C *¥X²{¤U¦Cª¬ªp­n§iª¾Âå®v¡G¤ß±ª¡B¤ß·i¹L³t¡B¯Ýµh¡B¦Ù¦×Ÿ§Ý¡B©ü¯t¡BÀYµh¡B ¼é¬õ¡B±Æ§¿§xÃø©Î«ùÄòªº©I§l§xÃø¡C

DL-Methylephedrine HCl  Tablet 25mg Tablet

«~¦W³W®æ DL-Methylephedrine HCl  Tablet 25mg Tablet
¼t        °Ó¤«¥Ð»sÃÄ
¥N        ¸¹OEPH
¦¨  ¥÷  ¦W DL-Methylephedrine Tablet 25mg/Tab.
¤¤¤å¦WºÙ "¤«¥Ð" ÆQ»Ä®ø±Û¥Ò°ò³Â¶ÀÆP¿õ
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics for systemic use / Alpha- and beta-adrenoreceptor agonists 
¥~        Æ[

»¡©ú®Ñ

¡@


Adrenalin inj. (Epinephrine 1ml/ml/amp.)

«~¦W³W®æ ADRENALIN INJECTION 1mg/ml/amp.
¼t        °Ó¤¤°ê¤Æ¾Ç»sÃÄ
¥N        ¸¹IBOS
¦¨  ¥÷  ¦W Epinephrine 1ml/ml/amp.
¤¤¤å¦WºÙ ¦w±o²z¨º¹çª`®g²G
ÃIJz¤ÀÃþ Cardiovascular system / Cardiac therapy / Cardiac stimulants excl. cardiac glycosides / Adrenergic and dopaminergic agents / Epinephrine 
¥~        Æ[

¡@

¡u¦¨  ¤À¡v:

¥»¾¯¨C¤ä(lml.)§t¦³µÇ¤W¸¢¯À(Epinephrine)lmg.¾A¦X¤é¥»Ãħ½¤è¦¬¸ü¤§µÇ¤W¸¢¯Àª`®g²G¤§³W®æ¡C

¡uÃÄ  ®Ä¡v:

1.¥»¾¯¤§¥D­n§@¥Î¬°¥æ·P¯«¸g¥½±é¿³¾Ä§@¥Î¡A¦]¦¹¹ï¤ßŦ¦åºÞ¤Î¥­·Æ¦Ù¦³¾÷¯à¤®¶i§@¥Î¡C

2.¥»¾¯¨ã¦³¦åºÞ¹B°Ê¯«¸g¤§¥½±é©Ê¨ë¿E§@¥Î¡A¦ý¬é¹ï¤j´`Àô¨t¤§¯ßºÞ(¥]§t²Ó¤p°Ê¯ß¤ò²ÓºÞ)¨ã¦³¦¬ÁY§@¥Î¡A¹ï¤p´`Àô¨tªÍŦ¦åºÞ§YµL¦¹¦¬ÁY§@¥Î¡C¹ï¤HÅé¤@¯ëŦ¾¹¨ã¦³¦p¤U§@¥Î:

(1)©I§l¾¹:®ðºÞ¡B¤ä®ðºÞ½üª¬¦Ù¤§¦¢½w¡C

(2)®ø¤Æ¾¹:¤Þ°_¹B°Ê­­¨î§@¥Î¡A¹ï°jª¼¬A¬ù¦Ù¡B«Õªù¬A¬ù¦Ù¥H¤Î¿éÁxºÞ¤§¦¬ÁY§@¥Î¡C

(3)¤l®c:¹ï«D§³®W¤l®c°_¦¢½w§@¥Î¡A¹ï§³®W¤l®c°_¦¬ÁY§@¥Î¡C

(4)²´·ú:´²¤jÀû¤Õ¡AÂX¤j²´µõ¡A¨Ï²´²y¬ð¥X¡A¨ÏÀþ½¤°hÁYµ¥¡C±ý¨ÏÀû¤Õ´²¤j¡A¬I¦æ0.Olmg.¥H¤W¤§ÀR¯ß¤ºª`®g§Y¥i¡A¦ý¥Ñ¥Ö¤Uª`®g§Y¨Ï¬I»P¦P¶q¥çµL¦¹®Ä¡C

3.¥»¾¯ª½±µ¨ë¿E¥æ·P¯«¸g¤§¥½±é¡A¨Ï³è²G¸¢¡BÖß²G¸¢¡B²\¸¢¤§¤Àªc¶q¼W¥[¡C

4.¨Ï¥Î¤Ö¶q¤§¥»¾¯¡A§Y¯à¦^´_¤w¯h³Ò¤§°©Àf¦Ù¤§ÅËÁY¤O¡C

5.¥»¾¯¨Ï°ò¥»·s³¯¥NÁ©ô²±¡C

6.¥»¾¯¦³¤Ï¨Ï¦åºÞÂX±i¤§§@¥Î¡A¦¹§Y©Ò¿×¦w±o²z¨º¹ç°f¤ÏÀ³¡A¦b¤Ú¦è¦h¤ó¯fªº³õ¦X¡A§Y¥Ñ¦¹¤Þ°_³Ì¤j¦åÀ£¤§­°¤U¡A¯ß³Õ¼Æ¤§´î¤Ö¡C

¡u¾AÀ³¯g¡v:

1.¹L±Ó¤ÏÀ³¤Þ°_¤§¥ð§J¡B©I§l¹DµjÅ˩γï¹D¤ô¸~¡C

2.¤ß¸õ°±¤î¤§«æ±Ï¡C

3.¤ä®ðºÞ©Ê®ð³Ý¡C

¡u¨Ï¥Î½d³ò¡v:

¤º¬ì:­G¥X¦å¡B¤ä®ðºÞ®ð³Ý¡B¤ºÅ¦¥X¦åµê²æÁ{¦M¡B¹ï«CÅð¯À©Î°sº¸¦ò´²¹L±Ó¯g¤§¹w¨¾¡B¤@®ñ¤ÆºÒ¤§¤¤¬r¡B´Óª«¯«¸g¨t¤§¾÷¯àÀˬd¡C

¤p¨à¬ì:¤ä®ðºÞ®ð³Ý¡B°²¦ºª¬ºA¡B©]§¿¯g¡C

¥~¬ì:¤j¥X¦å®É¤§µê²æ¡B¥~¶Ë©Ê¥ð§J¡B¥Ñ¤õ¶Ë¡B¿S¶Ë¡B¹qÀ»¤Þ°_¤§¤ßŦ³Â·ô¡B¦b´â¥é³Â¾K¤¤¤§«æ©Ê¤¤¬r¡C

¦Õ»ó«|³ï¬ì:¤â³N®É¤§¥X¦å¡C

²´¬ì:²´¬ì¤â³N(ÄŲ´²É¸~¡B­i±m¤Á°£¡B¥Õ¤º»Ù¤â³N¡B¤ô´¹ÅéºK¥X)¡C

ªc§¿¬ì:§¿¹D¥~¬ì(¤î¦å¥Î)¡C

°ü²£¬ì:¥Í²£®É¤§¥X¦å¡B¤l®c¥X¦å¡C

¡u¥Î  ªk¡v:

³q±`¦¨¤H¤@¤Ñ0.1~lml.(0.lmg~lmg.)«ö¨ä¥Øªºª`®g©ó¥Ö¤U¡B¦Ù¦×¡BÀR¯ß¤º¤Î¤ßŦ¤º¡A¦]¦U¤H¹ï¥»¾¯¤§·P¨ü©Ê»á¦³®t²§¡A¦]¦¹³Ìªì¨Ï¥Î0.2~0.3m1.µ{«×¬°§´¡C

¡u°Æ§@¥Î¡v:

¥»¾¯¤§­P¦º¤¤¬r¶q¬°³q±`¥Î¶q¤§¬ù500­¿¡A¹L¶q¨Ï¥Î·|¤Þ°_ÀYµh¡B¯t·w¡B¹Ã¦R¡B¤ß¸õ©ù¶i¡B¯Ý¤º­W´e¡B¤W¦æ©Ê¤¤¼Ï¯«¸g³Â·ô¡BÅé·Å¤U­°µ¥¡A·¥¶q¥H¤W¤§¤j¶q¨Ï¥Î¡A¦³®É¥Ñ©I§l³Â·ô¡B¤ßŦ³Â·ô¦Ó­P¦º¤`¡C

¡u¸T  §Ò¡v¡G

1.¹ï¥»¾¯¹L±Ó¤§µ{«×¡A¦]¦U¤H·P¨ü©Ê¤§¤£¦P¦Ó¦³®í²§¡A¦]¦¹³Ìªì¨Ï¥Î¶q¥H0.2~0.3m1.µ{«×¬°¦w¥þ¡C

2.¹ï¿}§¿¯f¡B¸}®ð¡B¤ßŦ¦åºÞ¯f(°Ê¯ß½F¡B°Ê¯ßµw¤Æ¯gµ¥)¡BµäÁYµÇ¡B³Ø¦å¡BªÍ¤§µoª¢©Ê¯f¯g¡A§¡¶·ÁקK¨Ï¥Î¡C¤×¨ä´c©Ê¥Òª¬¸¢¸~(¤Ú¦è¦h¤ó¯f)¯f±w¤§¤ßŦ¡A¹ï¥»¾¯«D±`¾U±Ó¡A¥²¶·¤p¤ß¨Ï¥Î¡C

3.¹ï¹x©T©Ê¤ä®ðºÞ®ð³Ý¤§¦Ñ¦~±wªÌ¡Aªø´Á³s¥Î¡C¦³µo¥Í¸£·¸¦å¤§¦MÀI¡A¥²¶·ÁקK¨Ï¥Î¡C

¡uÀxÂêk¡v:

¥»¾¯¶·¾B¥úÀx¦s©ó§N·t³B¡C

¡uª`  ·N¡v:

¥»ÃÄ­­¥ÑÂå®v¨Ï¥Î¡C

Lungtec Tab. (Bambuterol Hydrochloride 10mg/Tab.)

«~¦W³W®æ Lungtec Tab. (Bambuterol Hydrochloride 10mg/Tab.)
¼t        °Ó°·³ì«H¤¸ÂåÃĥͧޤ½¥q
¥N        ¸¹OBAM
¦¨  ¥÷  ¦W Bambuterol Hydrochloride 10mg/Tab.
¤¤¤å¦WºÙ ªÍ³Ý§J ¿õ 15²@§J
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics for systemic use / Selective beta-2-adrenoreceptor agonists / Bambuterol 
¥~        Æ[

¡@

»s³y¼t¡G °·³ì«H¤¸ÂåÃĥͧުѥ÷¦³­­¤½¥q
°·«O½X¡G A045178100
½Ã¸pBE®Ö­ã¦r¸¹¡G 0910062774¸¹
¦¨¤À¦W¡G bambuterol hydrochloride
¾AÀ³¹ï¶H¡G ¤ä®ðºÞ®ð³Ý¡C
¯SÂI¡G ¥»«~ªº¥D¦¨¤ÀBambuterol¡A¬OµÇ¤W¸¢ƒÒ·P¨ü¾¹¨ë¿E¾¯Terbutalineªº«eÅXª« (prodrug)¡C¥D­n¬O¨ë¿Eß2·P¨ü¾¹¡C ¦]¦Ó¹ï¤ä®ðºÞ¥­·Æ¦Ù²£¥ÍÃP¦¢§@¥Î¡A§í¨î¤º¥Í©ÊµjÅ˯ÀªºÄÀ©ñ¡A¨Ã¥B§í¨î¥Ñ¤º¥Í©Ê¶Ç¾Éª«½è¤Þ°_ªº¯B¸~¡A¥H¤Î¼W¥[Öß½¤ÅÖ¤òªº¹ø²M¤O¡C
¥Î¶q¤Î¥Îªk¡G ¥»ÃĶ·¥ÑÂå®v³B¤è¨Ï¥Î¡C
©ó§ÖºÎı«eªA¥Î¤@¦¸¡C¾¯¶qÀ³ÀH¤H¦Ó²§¡C
¦¨¤H:±ÀÂË°_©l¾¯¶q¬°10 mg¡CµøÁ{§É§@¥Î¦Ó©w¡A¦b1~2¬P´Á¥H«á¾¯¶q¥i¼W¥[¦Ü20 mg¡C
µÇ¥\¯à¤£¥þªº¯f¤H(GFR>=50ml/min)¡A±ÀÂË°_©l¾¯¶q¬°5 mg¡C
¸T§Ò¡G ¹ï¸Ó¾¯«¬ªº¥ô¦ó¦¨¤À©ÎTerbutaline¹L±ÓªÌ¡C
ª`·N¨Æ¶µ¡G 1.¹ïÀÀ¥æ·P¯«¸gÓiÃĪ«±Ó·P©Ê¼W¥[ªº±wªÌ¡A¨Ò¦pµLªk¾A·í±±¨îªº¥Òª¬¸¢¾÷¯à¤®¶iªÌ¡A À³¤p¤ß¨Ï¥Î¥»«~¡C¥Ñ©óß2¨ë¿E¾¯·|¼W¥[¦å¿}¿@«×¡A¦P®É±w¦³¿}§¿¯fªÌªA¥Î ¥»«~®É«Øij¼W¥[¦å¿}±±¨î¾¯¡Cß2¨ë¿E¾¯¯à¦¨¥\¦a¨Ï¥Î©ó«æ©ÊªvÀøÄY­«¯Ê¦å ©Ê¤ßŦ°IºÜ¡C¦ý¬O¡A¦bªvÀø¬Y¨Ç±wªÌ®É¡A³o¨ÇÃĪ«¥i¯à·|¤Þµo¤ß«ß¤£¾ã¡C
2.¥Ñ©óTerbutaline¤j³¡¤À¸g¥ÑµÇŦ±Æ¥X¡A¹ï©ó¨ã¦³ÄY­«µÇ¥\¯à¤£¥þªº±wªÌ¡A¨ä°_©l ¾¯¶qÀ³¤©¥H´î¶q¡C¨xµw¤Æªº±wªÌ¡A¨ä±N¥»«~¥NÁ¦ÜTerbutalineªº³~®|¡A­ÓÅ鶡 ªº®t²§©ÊµLªk¹w´ú¡A¥H­P©ó¬Û¦P¾¯¶qªº¥»«~¡A¦b¦³¨Ç¨xµw¤Æªº±wªÌÅ餺¯à²£¥Í¸û¥¿ ±`¤H¦hªºTerbutaline¡A¦Ó¦b¬Y¨Ç±wªÌÅ餺«h¥u¦³«D±`¤Ö©Î¨S¦³Terbutalineªº ²£¥Í¡A¨xµw¤Æªº±wªÌ¡A¥H¤Î¨ä¥L¦]¯À³y¦¨ÄY­«¨x¥\¯à¤£¥þªº±wªÌ¡A¨ä¤@¤Ñªº¾¯¶q¥²¶· ¦]¤H½Õ¾ã¡A­n¦Ò¼{¨ì¦³¨Ç­ÓÅ餣¯à±N¥»«~¥NÁ¦¨Terbutaline¡C¦]¦¹¡A±q¹ê¥Îªº¨¤ «×¨Ó¬Ý¡A³o¨Ç±wªÌÀ³ª½±µ§ë»P¨ä¬¡©Ê¥NÁª«¡ATerbutaline¬°¨Î¡C
°Æ§@¥Î¡G ®¶Å¸¡BÀYµh¡B±jª½©Ê¦Ù¦×µjÅˤΤ߱ªµ¥¤§¤£¨}¤ÏÀ³¡A¬°¤@¯ëÀÀ¥æ·P¯«¸gÓiÃĪ«©Ò¦@¦³¤§¯S©Ê¡C³o¨Ç °Æ§@¥Î¤j³¡¤À©óªvÀø1-2¬P´Á«á·|¦ÛµM®ø¥¢¡C
®e¶q¡G 2 ~ 1000¿õ¡A¶ì½¦²~¸Ë¡F¾Tºä²°¸Ë¡C

Buventol Easyhaler 200 micrograms/Dose (Salbutamol 200mcg/dose)

«~¦W³W®æ Buventol Easyhaler 200 micrograms/Dose (Salbutamol 200mcg/dose)
¼t        °ÓªâÄõ Orion ¤jÃļt
¥N        ¸¹OSALB
¦¨  ¥÷  ¦W Salbutamol 200mcg/dose
¤¤¤å¦WºÙ ªÍµÎ§´ °®¯»§l¤J¾¯
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Selective beta-2-adrenoreceptor agonists / Salbutamol 
¥~        Æ[

¨Ï¥Î»¡©ú¼v¤ù

¡@

¡@

 

¡i¾AÀ³¯g¡j

¥i°f©Êªý¶ë©Ê®ðºÞ¯e¯f±wªÌªº¤ä®ðºÞµjÅË¡B¹w¨¾¹B°Ê¤Þ°_ªº¤ä®ðºÞµjÅË¡C

¡i¥Îªk»P¾¯¶q¡j

¡E¼QÃú§l¤J¾¯ (12 ·³¥H¤W)¡G¨C 4-6 ¤p®É¼Q 2 ¤U¡C­YµLªk±±¨î¯gª¬¡A­n¥ß§Y´NÂå¡C *¹w¨¾¹B°Ê¤Þ°_ªº¤ä®ðºÞµjÅË (12 ·³¥H¤W)¡G¹B°Ê«e 15 ¤ÀÄÁ¼Q 2 ¤U¡C ¡E§l¤J·»²G (12 ·³¥H¤W)¡G2.5mg tid-qid¡C¥ÎµLµß¥Í²z­¹ÆQ¤ô±N 0.5ml ªº 0.5% ·»²Gµ} ÄÀ¦¨ 3ml¡C¨Ï¥ÎÃú¤Æ¾¹©ó 5-15 ¤ÀÄÁ¤º§l¤J¡C ¡E¿õ¾¯ (12 ·³¥H¤W)¡Gªì¾¯¶q 2-4mg tid-qid¡C¦b±wªÌ¯à°÷§Ô¨üªº±¡ªp¤U¡A³vº¥½Õ¾ã¾¯ ¶q¡C¨C¤é³Ì°ª¾¯¶q 32mg¡C ¡E¿}¼ß¡GºCºC¼W¥[¾¯¶q¡C
¯f±w¸s ¾¯¶q
> 14 ·³ ¤@¯ë¾¯¶q¬° 2mg ©Î 4mg tid-qid¡C¨C¤é³Ì°ª¾¯¶q 8mg qid¡C
6-14 ·³¨àµ£ ªì¾¯¶q¬° 2mg tid-qid¡A¨C¤é³Ì°ª¾¯¶q 24mg¡C
2-6 ·³¨àµ£ ªì¾¯¶q¬° 0.1mg/kg tid¡A¦ý¤£¥i¶W¹L 2mg tid¡C¥i³vº¥¼W¶q¦Ü 0.2mg/kg tid¡A¨C¤é³Ì°ª¾¯¶q 4mg tid¡C
¡E¦Ñ¦~¤H¤Î¹ï b-¥æ·P¯«¸g§@¥Î¾¯±Ó·PªÌ¡Gªì¾¯¶q 2mg tid-qid¡A¥²­n®ÉºCºC¼W¶q¦Ü 8mg 
tid-qid¡C
»s³y¼t¡G ªâÄõ Orion ¤jÃļt
°·«O½X¡G B021144145
»¡©ú¡G Buventol¬°¤@ºØªvÀø¤ä®ðºÞ®ð³Ýªº°®¯»§l¤J¾¯, ¥D¦¨¤ÀSalbutamol¬°¤@ºØ¿ï¾Ü©Ê¤A¤G«¬­P®Ä¾¯, ¥i¦³®Ä¦aÃP¦¢¤ä®ðºÞ¥­·Æ¦Ù, ¸Ñ°£«æ©Ê®ð³Ýµo§@, ¹w¨¾¹B°Ê©Ò¤Þ°_ªº®ð³Ý»PªvÀøºC©Êªý¶ë©ÊªÍ¯e¯f¡C
¦¨¤À¦W¡G Buventol Easyhaler 200mcg/dose inhalation powder
¾AÀ³¹ï¶H¡G ¤ä®ðºÞ®ð³Ý, ºC©Êªý¶ë©ÊªÍ¯e¡C
¯SÂI¡G Buventol °®¯»§l¤J¾¯¥D¦¨¤ÀSalbutamol¬°¤@¿ï¾Ü©Ê£]2 sympathomimetic, ¨ä¥iÄy¥Ñ¼W¥[¤ä®ðºÞ¥­·Æ¦Ù²Ó­M¤ºcAMP ªº§t¶q, ¦ÓÃP¦¢µjÅ˪º¤ä®ðºÞ¥­·Æ¦Ù¡C¦¹¥~, salbutamolÁÙ¥i§í¨îªÍ³¡²Õ´ÄÀ©ñ²Õ´Ói»P¨ä¥L¤¶½è»P¥[³t¤ä®ðºÞÅÖ¤òªº¹ø²M§@¥Î¡C
¥Î¶q¤Î¥Îªk¡G ¥»ÃĶ·¥ÑÂå®v³B¤è¨Ï¥Î¡C
¦¨¦~¤H»P12·³¥H¤Wªº«Äµ£:
«æ©Ê®ð³Ýµo§@©Î¹B°Ê«e: 100-400mcg, ³æ¤@¾¯¶q¨Ï¥Î¡C
ºC©Êºû«ùªvÀø©Î¹w¨¾®ð³Ý: ¨C¤Ñ2-4¦¸, ¨C¦¸100-400mcg, ­Õ­Y¯f±¡»Ý­n, ¥i±N¾¯¶q¼W¦Ü¨C¤Ñ2.4mg¡C
3-12·³«Äµ£
°¸µo©Ê®ð³Ýµo§@©Î¹B°Ê«e:100-200mcg, ³æ¤@¾¯¶q¨Ï¥Î¡C
ºC©ÊªvÀø©Î¹w¨¾®ð³Ý:¨C¤Ñ2-4¦¸, ¨C¦¸100-200mcg, ­Õ­Y¯f±¡»Ý­n, ¥i±N¾¯¶q¼W¦Ü¨C¤Ñ1.2mg ¡C
¸T§Ò¡G ¸T¥Î©ó¹ï¥»«~¤§¥ô¤@¦¨¤À¹L±ÓªÌ¡C
ª`·N¨Æ¶µ¡G ªø´Á¨Ï¥Î®ÉÀ³©w´ÁºÊ´ú±wªÌªº¯fª¬¥Hµû¦ô°_©l¨Ï¥Î§Üµoª¢»s¾¯©Î½Õ¾ã¾¯¶qªº»Ý­n©Ê¡C
°Æ§@¥Î¡G §l¤J©Êsalbutamolªº­@¨ü©Ê¤£¿ù, °Æ§@¥Î¥i¯àµo¥Í©ó°_©lªvÀø®É, ¥B³q±`»P¾¯¶q¦³Ãö¡C³Ì±`¨£ªº°Æ§@¥Î¬°¤ß±ª, ¾_Ÿ, ¤£¦w»PÀY·w, ¸û¤Öµo¥Íªº¬°°ª¦åÀ£, ¤f°®, ³ïÀY¨ë¿E©Ê¡C¨u¨£ªº¬°¤ä®ðºÞµjÅË»P¦Ù¦×µ±µh¡C
®e¶q¡G °®¯»§l¤J¾¯«¬, ¨C²°ÃÄ«~¤º¦³¤@­Ó§l¤J¾¹(¤º§t200¦¸§l¤J¾¯¶q)»PÅ@»\¡C

Ventolin Inhaler 100 micrograms (Salbutamol 100mcg/dose)

«~¦W³W®æ Ventolin Inhaler 100 micrograms (Salbutamol 100mcg/dose)
¼t        °Ó¸¯Äõ¯À Ãļt
¥N        ¸¹OVENT
¦¨  ¥÷  ¦W Salbutamol 100mcg/dose
¤¤¤å¦WºÙ ªx±oªL ©w¶q¼QÃú¾¯
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Selective beta-2-adrenoreceptor agonists / Salbutamol 
¥~        Æ[

»¡©ú®Ñ   (1)  (2)

¨Ï¥Î»¡©úµu¤ù

¡@

¡@


Seretide Evohaler  250mcg (250mcg fluticasone, 25mcg Salmeterol / dose)

«~¦W³W®æ Seretide Evohaler 250mcg
¼t        °Ó¸¯Äõ¯À
¥N        ¸¹OSEREEV
¦¨  ¥÷  ¦W Fluticasone 250mcg; Salmeterol 25mcg per dose
¤¤¤å¦WºÙ ¨ÏªÍ®õ 250 mcg
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Adrenergics and other drugs for obstructive airway diseases / Salmeterol and other drugs for obstructive airway diseases 
¥~        Æ[

»¡©ú®Ñ  

(1)  (2)

¨Ï¥Î»¡©úµu¤ù

¡@

¡@


Seretide Accuhaler 250mcg (250mcg fluticasone, 50mcg Salmeterol / dose)

«~¦W³W®æ Seretide Accuhaler 250mcg (250mcg fluticasone, 50mcg Salmeterol / dose)
¼t        °Ó¸¯Äõ¯À
¥N        ¸¹OSERE
¦¨  ¥÷  ¦W 250mcg fluticasone, 50mcg Salmeterol / dose
¤¤¤å¦WºÙ ¨ÏªÍ®õ¢±¢´¢¯·Ç¯Ç°®¯»§l¤J¾¯
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Adrenergics and other drugs for obstructive airway diseases / Salmeterol and other drugs for obstructive airway diseases 
¥~        Æ[

»¡©ú®Ñ  

(1)  (2) (3)  (4)

¨Ï¥Î»¡©úµu¤ù

¡@

¡@


Symbicort 120 doses (160mcg budesonide, 4.5mcg formoterol / dose)

«~¦W³W®æ Symbicort 120 doses (160mcg budesonide, 4.5mcg formoterol / dose)
¼t        °ÓAstraZenica
¥N        ¸¹OSYM
¦¨  ¥÷  ¦W 160mcg budesonide, 4.5mcg formoterol / dose
¤¤¤å¦WºÙ §l¥²ÂX ©w¶q¯»ª¬§l¤J¾¯
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Adrenergics and other drugs for obstructive airway diseases
¥~        Æ[

»¡©ú®Ñ  

(1)  (2) (3)  (4)

¨Ï¥Î»¡©úµu¤ù

¡@

¡@


Ipratran Inhalation Solution ( Ipratropium 0.25mg/ml  2ml/amp.)

«~¦W³W®æ Ipratran Inhalation Solution ( Ipratropium 0.25mg/ml  2ml/amp.)
¼t        °Ó «HªF¥Í§ÞªÑ¥÷¦³­­¤½¥q
¥N        ¸¹OATRO
¦¨  ¥÷  ¦W Ipratropium 1.25mg/ml    2ml/amp.
¤¤¤å¦WºÙ ¯q¼³³Ý§l¤J²G¢¯¡D¢±¤½µ·¢A¤½¼¼¡©«HªF¡ª
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Other drugs for obstructive airway diseases, inhalants / Anticholinergics / Ipratropium bromide 
¥~        Æ[

[¾AÀ³¯g]
ºC©Êªý¶ë©Ê¤ä®ðºÞª¢¡B¤ä®ðºÞ®ð³Ý¡C

[¥Îªk/¥Î¶q]
¥»¾¯¥²¶·¨Ï¥ÎÃú¤Æ¾¹¡A¥B¨Ï¥Î¤è¦¡¶·¥ÑÂå®v«ü¾É¡C
¥»¾¯¤£¥i¥Î©óª`®g¡C
ºû«ùªvÀø¨C¦¸1³æ¤@¾¯¶q¡A¨C¤Ñ3¦Ü4¦¸¡F«æ©Êµo§@¨C¦¸1³æ¤@¾¯¶q¡A¾¯¶q¥i­«ÂЦܯf¤H¯gª¬Ã­©w¡C

¡@


Saldolin Inhalation Solution (Salbutamol 2mg/ml  2.5ml/amp.)

«~¦W³W®æ SALDOLIN INHALATION SOLUTION 2MG/ML S.T
¼t        °Ó «HªF¥Í§ÞªÑ¥÷¦³­­¤½¥q
¥N        ¸¹OVEN
¦¨  ¥÷  ¦W Salbutamol 2mg/ml  2.5ml/amp.
¤¤¤å¦WºÙ µÎ¼wªL§l¤J²G¢±¤½µ·¢A¤½¼¼
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Selective beta-2-adrenoreceptor agonists / Salbutamol 
¥~        Æ[

[¾AÀ³¯g]
¤ä®ðºÞµjÅË¡B«æ©ÊÄY­«©Ê®ð³Ý¡C

[¥Îªk/¥Î¶q]
¥»¾¯¥²¶·¨Ï¥ÎÃú¤Æ¾¹¡A¥B¨Ï¥Î¤è¦¡¶·¥ÑÂå®v«ü¾É¡C
¥»¾¯¤£¥i¥Î©óª`®g¡C
¨C¦¸¤@³æ¤@¾¯¶q¡A¤@¤é±o­«½Æ¥|¦¸¡C


Butanyl Inhalation Solution  (Terbutaline Sulfate 2.5mg/ml  2ml/amp.)

«~¦W³W®æ BUTANYL INHALATION SOLUTION 2.5MG/ML (TERBUTALINE SULFATE) "S.T."
¼t        °Ó «HªF¥Í§ÞªÑ¥÷¦³­­¤½¥q
¥N        ¸¹OTER
¦¨  ¥÷  ¦W Terbtaline sulfate  2.5mg/ml  2.5ml/amp.
¤¤¤å¦WºÙ ¥²©Z¹ç§l¤J²G¢±¡D¢´¤½µ·¢A¤½¼¼
ÃIJz¤ÀÃþ Respiratory system / Drugs for obstructive airway diseases / Adrenergics, inhalants / Selective beta-2-adrenoreceptor agonists / Terbutaline 
¥~        Æ[

»¡©ú®Ñ

¡@

¡@

¡@

¦^¨ì¥Ø¿ý